HIGHBRIDGE CAPITAL MANAGEMENT LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 24 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2022$4,723
-100.0%
23,616,0000.0%0.13%
-45.1%
Q3 2022$16,885,0000.0%23,616,0000.0%0.24%
-38.4%
Q2 2022$16,885,000
-10.1%
23,616,000
-5.0%
0.38%
-11.9%
Q1 2022$18,774,000
+8.6%
24,866,0000.0%0.44%
+15.9%
Q4 2021$17,282,000
+9.1%
24,866,000
+2.1%
0.38%
-10.0%
Q3 2021$15,838,000
-12.4%
24,366,0000.0%0.42%
-16.4%
Q2 2021$18,076,000
-21.0%
24,366,000
-19.0%
0.50%
-45.1%
Q1 2021$22,875,000
-33.4%
30,066,000
-38.1%
0.91%
-30.7%
Q4 2020$34,360,000
+10.7%
48,566,000
+4.3%
1.32%
-21.3%
Q3 2020$31,025,000
+43.3%
46,566,000
+30.9%
1.67%
-9.2%
Q2 2020$21,651,000
+92.4%
35,566,000
+96.9%
1.84%
+53.0%
Q1 2020$11,252,000
-7.2%
18,066,000
-5.2%
1.20%
-10.1%
Q4 2019$12,121,000
+162.1%
19,066,000
+72.3%
1.34%
+98.5%
Q3 2019$4,625,000
-63.5%
11,066,000
-38.5%
0.68%
+80.5%
Q4 2018$12,670,00018,000,0000.37%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Jabre Capital Partners S.A. 3,500,000$2,732,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 8,721,000$6,769,0000.82%
CAMDEN ASSET MANAGEMENT L P /CA 32,275,000$24,949,0000.70%
PFM Health Sciences, LP 57,632,000$44,730,0000.66%
Partner Investment Management, L.P. 768,000$596,0000.46%
SYMPHONY ASSET MANAGEMENT LLC 1,000,000$776,0000.21%
SSI INVESTMENT MANAGEMENT LLC 3,000,000$2,319,0000.18%
PointState Capital LP 12,000,000$9,342,0000.12%
MIZUHO SECURITIES USA LLC 2,000,000$1,548,0000.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,000,000$1,546,0000.11%
View complete list of CLOVIS ONCOLOGY INC shareholders